Prospective Study of Hydroxocobalamin for Acute Cyanide Poisoning in Smoke Inhalation
To access this article, please choose from the options below
Supervising editor: E. Martin Caravati, MD, MPHAuthor contributions: All authors contributed to the design, conduct, or analysis of the study and the preparation of the article, and all approved the final version for submission. FJB takes responsibility for the paper as a whole.Funding and support: Data analysis for this study and medical writing assistance with the article were supported by EMD Pharmaceuticals, an affiliate of Merck KgaA. No pharmaceutical company was involved, financially or otherwise, in the design or conduct of the study. Drs. Baud and Borron have been consultants for EMD Pharmaceuticals.Reprints not available from the authors.
PII: S0196-0644(07)00217-X
doi:10.1016/j.annemergmed.2007.01.026
© 2007 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Is Hydroxocobalamin Safe and Effective for Smoke Inhalation? Searching for Guidance in the Haze
